ABOUT US

The first platform built to predict mental health crises — before they happen

Entrelacs is an AI-powered preventive mental health platform that screens, matches, and monitors individuals with clinical precision — detecting deterioration weeks before crisis, so the right support arrives before it's urgently needed.

Built on three years of R&D, 80,000+ research articles, and clinical validation across 8 countries and 37 global markets, Entrelacs brings together dynamic psychometric modeling, conversational AI, and continuous monitoring into a single platform — designed for employers, clinicians, and health systems.

We exist because mental health is the only area of medicine without a reliable early warning system. We're here to change that.

Vision & mission

A world where mental health crises are predicted, prevented, and no longer inevitable.

Vision

A future where mental health care works like every other area of medicine — with routine screening, early detection, and proactive intervention as the standard, not the exception.

Mission

To make preventive mental health care universally accessible through advanced psychometrics and clinical-grade AI — giving individuals, clinicians, employers, and health systems the tools to act before crisis strikes.

Our three pillars

Precision

Screen with clinical accuracy, not guesswork. A 15-minute conversational assessment replaces fragmented questionnaires with objective, multi-dimensional risk stratification.

Personalization

Match to the right care pathway, first time. AI connects each individual to the most effective intervention from day one — reducing failed treatments and accelerating improvement by 2–3x.

Prevention

Detect deterioration before it becomes crisis. Continuous monitoring tracks passive signals between sessions, alerting care teams weeks before a crisis — turning reactive care into proactive care.

Our story

Born from an uncomfortable truth. Built to fix it.

Entrelacs began with a question that sounds simple but turns out to be radical:

What if the average
patient doesn't exist?

Person holding their head in their hands

For decades, mental health science has operated on a shared assumption: find the pattern that fits most people, build around that center, and apply it broadly. It's a reasonable approach. But for a significant share of the people those tools are meant to help, it produces the wrong answer. Depression doesn't look the same in every person. Neither does anxiety, loneliness, or burnout. A scale score that means one thing in one individual may mean something entirely different in another — not because the instrument is broken, but because human beings genuinely differ in how they experience psychological states. Recommending care based on that score, without understanding those differences, causes real harm. And because every misdiagnosis compounds — wrong pathway, wrong treatment, months or years lost — the cost of getting it wrong is preventable deterioration.

This isn't a fringe hypothesis. It's what the research increasingly shows. And it's what many clinicians — and many patients — already know from experience: finding the right mental health care, matched to who you actually are, is genuinely hard. When your assessment doesn't actually capture who you are, the care pathway it points to may be the wrong one entirely. And finding the right care — matched to who you actually are — is already genuinely hard, even for people with clinical training and system knowledge. The technology to do better now exists. What was missing was the will — and the team — to build it properly.

Entrelacs was founded to close that gap. Built on a foundation of open science — informed by 80,000+ research articles, and developed through years of interviews with individuals in 8 countries — Entrelacs brings together AI, dynamic psychometric modeling, and continuous monitoring to do what no mental health tool has done before: assess, match, and track the individual, not the average. And because the platform understands who each person is — not just what their score is — it can do something no reactive system can: identify deterioration before it becomes crisis, and connect people to the right support before it’s urgently needed.

Today, Entrelacs is moving toward CE Mark certification in 2027, with strategic partnerships spanning Stanford, UC Davis, Oxford, and the Psychological Science Accelerator — and a clear commercial pathway into the employers, health systems, and clinical networks that need it most.

Founder story

The scientist who stopped believing in the average person.

Portrait of Dr. Hans Rocha IJzerman

Dr. Hans Rocha IJzerman

CEO & Co-Founder

It took two decades inside the mainstream to understand exactly why it was asking the wrong question.

"Entrelacs isn't built for the average patient — because that patient doesn't exist. It's built for the actual, specific, irreducibly individual human being who needs care."

A scientist who had spent years working within the mainstream — and slowly, reluctantly, became convinced it was asking the wrong question. A clinician who saw daily what happened when tools ignored those differences. A family that had felt the cost firsthand. That combination is what became Entrelacs.

Dr. Hans Rocha IJzerman left the Netherlands at 18 to play basketball in America. He ended up in rural Pennsylvania, at a small Benedictine college in the hills — Saint Vincent, where Fred Rogers, the beloved American television host known as Mister Rogers, had studied theology and first developed the convictions that would define his life’s work. The Benedictine monks who shaped the college had followed the same Rule for fifteen centuries: welcome every stranger, attend to every individual, treat no person as interchangeable with any other. It was something you could actually feel — in the way strangers were welcomed, in the weight given to listening, in the assumption that every person in the room had something irreplaceable to offer.

For a young Dutch kid far from home, navigating a culture not his own, something about that community lodged deep. Not the theology — but the underlying conviction that every human being is specific, irreducible, and not interchangeable with any other.

It's a conviction his own life has never let him forget. His family is Brazilian, Dutch, and French all at once — his children grow up navigating languages and worlds that don't map cleanly onto each other. The idea that a single instrument, designed for a single 'average' human, could capture what any one of them is going through has always felt, to him, self-evidently absurd.

For two decades, that conviction sat uneasily alongside the dominant logic of his own field.

Early in his career, Hans immersed himself in the study of honor culture — fascinated by how profoundly context shapes behavior and self-understanding. The lesson the data kept teaching was the same one he’d felt instinctively: who a person is changes what everything means. The same action, the same word, the same experience — interpreted through a different life, a different culture, a different self — is not the same thing.

But mainstream psychology, including his own field, kept reaching for the average. Measure large groups. Find the central tendency. Build tools around that center. It was practical. It was scalable. And for a long time, Hans worked within that logic too — because it was the field’s logic, and because the tools to do otherwise didn’t yet exist. What changed, slowly and then undeniably, was the evidence.

The moment the research made this undeniable came through an unexpected subject: romantic love. Hans and his collaborators set out to test whether the standard instruments used to measure relationship quality actually measured the same thing across different people. The answer was no — clearly, empirically, reproducibly no. Of course people experience love differently depending on who they are. And if that was true for love, the implications for depression, anxiety, loneliness, and every other psychological construct that clinical tools relied on were significant. The average wasn't just imprecise. It was systematically missing something.

The clinical cost of that gap was something Hans saw through his partner, Daniela, a psychologist with 15 years of practice. She encountered it constantly — the difficulty of interpreting scale scores that didn't mean what they appeared to mean, the real risk of sending someone down the wrong treatment pathway because the instrument hadn't been built to understand them as an individual. Paul Meehl had spent decades arguing that clinicians needed better actuarial tools to translate assessment data into good decisions. Decades later, the tools still hadn't caught up.

And then there was the experience — shared, in some form, by most families — of trying to find the right mental health care for someone you love. Not care in the abstract. The right care, for this person, now. Even with clinical training and with system knowledge. The mismatch between individual need and available support is not a minor inefficiency. It causes harm that compounds.

A scientist who had spent years working within the mainstream — and slowly, reluctantly, became convinced it was asking the wrong question. A clinician who saw daily what happened when tools ignored those differences. A family that had felt the cost firsthand. That combination is what became Entrelacs.

Entrelacs isn't built for the average patient — because that patient doesn't exist. It's built for the actual, specific, irreducibly individual human being who needs care.

Leadership team

Purpose-built expertise across science, technology, and healthcare.

Dr Hans Rocha IJzerman

Dr Hans Rocha IJzerman

CEO & Co-Founder

WHO & EU mental health policy advisor. University of Oxford affiliate researcher. Principal Investigator of the EU's €3M LONELY-EU Horizon Europe project. Published researcher with 10,000+ academic citations and one of the world's leading experts on social connection and mental health.

Miguel Silan

Miguel Silan

Chief Scientific Officer

Associate Director of the Psychological Science Accelerator — a global research network spanning 80+ countries. PhD in Psychology, specializes in large-scale studies of complex psychological systems. Author of 1,200+ academic citations. Led flagship multi-country behavioral studies across 20+ countries to establish culturally robust, mutli-domain measurement frameworks. The scientific backbone behind Entrelacs' cross-cultural validation and psychometric methodology.

Felix Moses

Felix Moses

Chief Technology Officer

Engineer and AI builder with deep experience in work with multidisciplinary teams to build market ready solutions. Expert in full-stack development, GCP infrastructure, and secure data pipelines — the architect behind Entrelacs' technical foundation.

Extended leadership team

Daniela Rocha Lopes

Daniela Rocha Lopes

Chief Clinical Officer

Clinical psychologist with 15+ years of experience in mental health practice and operations. Director-General of Solstice Psychologues. Ensures clinical integrity across every element of the Entrelacs platform.

Hilary Johnson

Hilary Johnson

Chief Product Officer

Former VP Product at Unmind. 15+ years in digital health UX. Brings world-class product leadership to Entrelacs' user experience and clinical workflows.

Matthew Reed

Matthew Reed

Chief Financial Officer

Finance executive with 15 years in clean energy and regulated industries. Former EDF Group executive. Has overseen $26B raised in ESG capital throughout his career. Leads Entrelacs' financial strategy and investor relations.

Cristina Claver Sicilia

Cristina Claver Sicilia

Chief Operations Officer

PharmD, MBA. Healthcare operations expert with deep experience leading pharmaceutical strategy implementation across Europe. Drives operational excellence and EU market access for Entrelacs.

Strategic advisors

Guided by the minds shaping the future of AI, behavioral science, and global health.

Dr. Michal Kosinski

Dr. Michal Kosinski

Stanford University

World-renowned expert in AI-driven behavioral prediction and psychometrics. His research on digital footprints and psychological profiling has been cited over 25,000 times. Advises on Entrelacs' AI methodology and behavioral prediction models.

Jillian Miranda

Jillian Miranda

Medtech Growth Strategist

Previously scaled multiple digital health companies from pilot to global adoption. Expert in healthcare go-to-market strategy and B2B2C models. Guides Entrelacs' commercial strategy and enterprise growth.

Ron Ivey

Ron Ivey

Founder, HumanConnection.AI

Thought leader in AI ethics and responsible AI deployment in healthcare settings. Advises on regulatory positioning, ethical AI practices, and responsible deployment across clinical environments.

Carson Kelly

Carson Kelly

Compassion 2.0

Tech veteran and Compassion 2.0 advocate. Advises on embedding compassion-driven models into our platform.

Emorie Beck

Emorie Beck

UC Davis

Leading expert in personalized psychological measurement and individual differences research. Guides the psychometric methodology and measurement science that underpins the Entrelacs assessment engine.

Contact us

Let's build the future of mental health care together

Whether you're an employer, clinician, health system, investor, or researcher, we'd love to hear from you.

For Employers & Health Systems

Request a demo and ROI assessment tailored to your organization.

Request a Demo

For Clinicians

See how Entrelacs integrates into your clinical workflow.

Request a Demo

For Investors & Partnerships

Explore collaboration, research partnerships, or investment opportunities.

Request a Demo

Precision

Personalization

Prevention

The future of mental health care is here

Experience the first platform that combines clinical precision with personalized insights and preventive monitoring. Join leading organizations already building the future of mental wellness.